Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73,819,979
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
6,797,480
-
Shares change
-
+6,787,480
-
Total reported value, excl. options
-
$265,100,975
-
Value change
-
+$264,710,973
-
Number of buys
-
43
-
Price
-
$39.00
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q4 2019
As of 31 Dec 2019 RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,797,480 shares of stock of the company.
Largest 10 holders included TANG CAPITAL MANAGEMENT LLC, VHCP Management III, LLC, RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, BOXER CAPITAL, LLC, TIEDEMANN ADVISORS, LLC, Invesco Ltd., and FRANKLIN RESOURCES INC.
This table shows 44 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.